(0.10%) 5 522.50 points
(0.13%) 39 896 points
(0.21%) 19 793 points
(-0.02%) $81.61
(0.68%) $2.83
(-0.29%) $2 337.60
(0.17%) $29.58
(0.35%) $1 005.30
(0.02%) $0.932
(-0.05%) $10.53
(0.01%) $0.788
(-0.84%) $87.26
10.88% $ 0.632
Live Chart Being Loaded With Signals
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications...
Stats | |
---|---|
Dzisiejszy wolumen | 116 935 |
Średni wolumen | 26 314 |
Kapitalizacja rynkowa | 4.81M |
EPS | $-0.160 ( Q1 | 2024-05-09 ) |
Następna data zysków | ( $0 ) 2024-08-12 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.850 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00800 (1.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-14 | Kaufman Jonathan H | Buy | 10 000 | Common Stock |
2024-03-15 | Pruchnic Ryan | Buy | 25 000 | Stock Options |
2024-03-15 | Yoshimura Naoki | Buy | 25 000 | Stock Options |
2024-03-15 | Chancellor Michael B | Buy | 80 000 | Stock Options |
2024-03-15 | Birder Lori | Buy | 25 000 | Stock Options |
INSIDER POWER |
---|
80.39 |
Last 30 transactions |
Buy: 1 046 762 | Sell: 360 000 |
Lipella Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lipella Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $449 617 |
Zysk brutto: | $447 932 (99.63 %) |
EPS: | $-0.770 |
FY | 2023 |
Przychody: | $449 617 |
Zysk brutto: | $447 932 (99.63 %) |
EPS: | $-0.770 |
FY | 2022 |
Przychody: | $184 156 |
Zysk brutto: | $-2.36M (-1 283.43 %) |
EPS: | $-0.450 |
FY | 2021 |
Przychody: | $259 347 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.325 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Lipella Pharmaceuticals
Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej